Pediatric Medical Devices Market Advances as Specialized Care, Imaging Innovation and Neonatal Technologies Expand Demand

BOSTON, Aug. 26, 2026 — Demand for pediatric medical devices is expanding as healthcare systems seek equipment designed around the distinct physiological and clinical needs of infants, children and adolescents. According to Next Move Strategy Consulting, the global pediatric medical devices market was valued at USD 36.07 billion in 2024 and is projected to reach USD 58.24 billion by 2030, representing a 8.3% compound annual growth rate (CAGR) from 2025 to 2030. The market is being shaped by childbirth trends, investment in healthcare infrastructure, specialized pediatric care requirements and advances in diagnostic technologies.

View the

Pediatric Medical Devices Market report from Next Move Strategy Consulting

Request the FREE Sample Here

Pediatric Medical Devices Market Growth and Outlook

The expanding market reflects the need for medical technologies that accommodate patients whose anatomy, physiology and care requirements change significantly throughout childhood. The U.S. Food and Drug Administration defines pediatric patients for medical-device purposes as those 21 years or younger at diagnosis or treatment and notes that children can differ from adults in size, body structures, developmental stage, activity level and long-term device-use considerations.

Next Move Strategy Consulting’s analysis uses 2024 as the base year and covers a 2025–2030 forecast period. The study segments the market by product type, age group, end user and geography. Product categories include diagnostic imaging devices, cardiology devices, anesthesia and respiratory-care devices, in vitro diagnostic devices, telemedicine, monitoring devices and neonatal intensive-care-unit devices. Age groups include neonates, infants, children and adolescents, while end users include research and academic institutes, hospitals, ambulatory surgery centers and pediatric clinics.

Birth and Neonatal Care Needs Support Demand

The need for specialized neonatal and pediatric equipment is closely connected with continued demand for high-quality care around birth. The World Health Organization estimates that 13.4 million babies were born preterm in 2020, equivalent to about one in 10 live births. WHO identifies complications from preterm birth as a leading cause of death among children under five, emphasizing the importance of effective neonatal care and interventions.

These clinical requirements create demand for technologies capable of monitoring fragile patients, supporting respiratory care, providing diagnostic imaging and assisting clinicians in neonatal intensive-care environments. Next Move Strategy Consulting identifies increasing childbirths globally and the resulting need for specialized equipment for infants and young patients as a core growth driver for the market.

Pediatric-Specific Design Remains a Critical Requirement

Unlike many adult devices, pediatric technologies frequently need to accommodate rapid changes in patient size and development. FDA guidance notes that devices designed or studied for children must account for needs such as growth, active lifestyles and differences in metabolism. The agency also maintains specific guidance on premarket assessment and the use of clinical evidence for pediatric indications.

These requirements can make pediatric device development more complex and contribute to longer development and approval pathways. Next Move Strategy Consulting identifies strict regulations, clinical requirements and compliance costs as constraints that can delay commercialization and increase costs for manufacturers.

At the same time, the regulatory environment is supporting more structured development. The FDA’s Pediatric Device Consortia program provides innovators with regulatory, engineering, prototyping, testing and clinical-development support, and the program was reauthorized for fiscal years 2023 through 2027.

Ultrasound, AI and Connected Diagnostics Create New Opportunities

Technology innovation is opening additional avenues for pediatric care. Next Move Strategy Consulting highlights advances in ultrasound as a significant opportunity, particularly where improved visualization can support diagnosis and monitoring in young patients.

Recent industry developments demonstrate how these technologies are becoming more pediatric-focused. In April 2024, Philips announced a long-term collaboration with Nicklaus Children’s Health System involving AI-enabled MRI and ultrasound technologies. The systems are designed to support faster exams, improve diagnostic confidence and enhance the experience of children undergoing imaging procedures.

Philips also identifies small transducers, high frame rates and AI-enabled tools as capabilities supporting pediatric echocardiography, illustrating the broader shift toward imaging technologies tailored to smaller patients and specialized clinical workflows.

Digital connectivity is extending beyond hospital imaging. Baxter introduced digital image-capture capabilities for its Welch Allyn PanOptic Plus ophthalmoscope in 2023, allowing clinicians to capture and share eye images digitally during examinations.

Government Healthcare Investment Supports Market Development

Investment in healthcare infrastructure is another factor influencing demand. Next Move Strategy Consulting identifies rising government healthcare expenditure as a market driver, particularly where countries are expanding healthcare capacity and improving access to specialized medical services.

Such investment can support purchases of diagnostic, monitoring, respiratory, neonatal and surgical technologies while also improving the infrastructure needed to deploy sophisticated pediatric devices. For manufacturers, these changes create opportunities across both established healthcare systems and developing markets where pediatric-care capacity is expanding.

North America Leads as Asia-Pacific Builds Momentum

North America currently dominates the pediatric medical devices market, according to Next Move Strategy Consulting, and the region is expected to retain its leading position through the forecast period. The report connects regional demand with child-focused healthcare initiatives, specialized care requirements and investment in advanced medical infrastructure.

Asia-Pacific, meanwhile, is expected to progress steadily as demand for pediatric diagnostic and treatment technologies grows. Next Move Strategy Consulting points to birth volumes, expanding healthcare infrastructure and the availability of hospitals across countries including China, India, Japan and Australia as factors supporting regional demand.

“The pediatric medical devices market is increasingly defined by the need to combine clinical precision with technologies designed for the unique developmental and physiological characteristics of younger patients,” said a spokesperson at Next Move Strategy Consulting. “Advances in imaging, monitoring, neonatal care and connected technologies are creating new opportunities while regulatory and clinical requirements continue to shape product development.”

Industry and Competitive Landscape

The competitive environment includes GE HealthCare, Baxter, Siemens Healthineers, Philips, Boston Scientific, Abbott, Medtronic, Stryker, Roche, Cardinal Health, Raydiant Oximetry and Hamilton Medical, among other healthcare technology and medical-device companies. Next Move Strategy Consulting reports that companies are pursuing product launches, collaborations and other strategic initiatives to broaden capabilities and address pediatric-care requirements.

Recent product activity illustrates the direction of the sector. Philips’ pediatric imaging collaboration emphasizes AI-enabled workflows and patient-experience technologies, while Baxter’s digital ophthalmic imaging capabilities demonstrate how connected tools can support information sharing during routine examinations.

Pediatric Medical Devices Market Report Overview

The Next Move Strategy Consulting Pediatric Medical Devices Market report provides market estimates and forecasts for 2025–2030, including the market’s size, CAGR, growth drivers, restraints, technology opportunities, segmentation, regional trends and competitive landscape. The study analyzes the industry by product type, age group, end user and geography, covering North America, Europe, Asia-Pacific and the Rest of the World.

 

About Next Move Strategy Consulting

Next Move Strategy Consulting is a market research and consulting company providing market intelligence, industry analysis, competitive insights, and strategic research across a wide range of industries and geographic markets.

As pediatric healthcare systems continue to prioritize specialized diagnostics, neonatal support, monitoring and child-specific treatment solutions, the evolution of device technology will remain important for manufacturers, healthcare providers, investors, technology companies and policymakers. Continued attention to regulatory developments, pediatric clinical needs, imaging innovation and healthcare infrastructure will help stakeholders assess where opportunities and challenges are emerging across the global pediatric medical devices market.